Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States
Samir Kapadia, MD, is the Chairman of the Department of Cardiovascular Medicine at Cleveland Clinic. He is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Kapadia is board-certified in internal medicine, cardiology, and interventional cardiology.
Specialty/Clinical interests: Percutaneous treatment for valve disease, transcatheter aortic valve replacement (TAVR), Mitraclip, transcatheter mitral valve interventions, complex coronary interventions, atrial septal defect (ASD), paravalvular leak closure and patent foramen ovale (PFO) closure.
Dr. Kapadia has performed more than 1500 TAVR procedures and thousands of other cardiovascular procedures throughout his career. He has published more than 1000 peer reviewed papers.
Disclosure(s): No financial relationships to disclose
VALVE COMPLICATIONS AND MANAGEMENT | SESSION ONE
Saturday, March 8, 2025
2:00 PM – 3:43 PM ET
VALVE COMPLICATIONS AND MANAGEMENT | SESSION TWO
Saturday, March 8, 2025
3:43 PM – 5:40 PM ET
Sunday, March 9, 2025
10:40 AM – 11:00 AM ET
LATE-BREAKING CLINICAL TRIALS | STRUCTURAL AND LAA
Sunday, March 9, 2025
2:00 PM – 3:30 PM ET
Live Case St. Johannes Hopital Dortmund | Dortmund, Germany
Monday, March 10, 2025
8:00 AM – 8:45 AM ET
EMBOLIC PROTECTION AND PREVENTION
Monday, March 10, 2025
1:00 PM – 1:45 PM ET
State of the ART Devices to Prevent Stroke During TAVR
Monday, March 10, 2025
1:00 PM – 1:08 PM ET
Panel Discussion | Who Should Get Embolic Protection Device During TAVR?
Monday, March 10, 2025
1:30 PM – 1:45 PM ET
LATE-BREAKING CLINICAL SCIENCE | STRUCTURAL II
Monday, March 10, 2025
2:00 PM – 3:30 PM ET